Fig. 3
From: Clinical considerations for the design of PROTACs in cancer
A RNA expression in TPM of targets in tumoral tissues with the highest incidence according to GEPIA2. B RNA expression in TPM of ligands in tumoral tissues with the highest incidence according to GEPIA2. C Targets and ligases with TPM > 32. BRCA: Breast Invasive Carcinoma, COAD: Colon adenocarcinoma, LUAD: Lung adenocarcinoma, PRAD: Prostate adenocarcinoma, STAD: Stomach adenocarcinoma